The inflammasome components including NLRP1, NLRP3, PYCARD, caspase-1,−5, and−8 and their downstream effectors IL-1β and IL-18 were markedly upregulated in mild and severe AD at transcriptional level (Saresella et al., 2016). Here, NLRP3 is linked to Alzheimer disease.